422 results on '"Mesothelioma, Malignant"'
Search Results
2. Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
3. Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing (BASECAMP-1)
4. Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies
5. A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma
6. The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma (FAPI-PM)
7. IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers (IMMUNORARE5)
8. Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
9. Immune Microenvironment and Gene Expression Profiling in Mesothelioma (Imaging-Meso)
10. Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study) (CHIMERA)
11. Long Term Follow-up of Mesothelioma Patients and Their Family Members With Germline Mutations in BAP1 and Other Genes
12. Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
13. A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients with Solid Tumors (INVOKE)
14. Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
15. A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM)
16. Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome
17. Rinatabart Sesutecan (Rina-S) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) (PRO1184-001)
18. Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma
19. BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma (BEAT-meso)
20. Testing the Addition of Immunotherapy Before Surgery for Patients with Sarcomatoid Mesothelioma
21. MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma (eVOLVE-Meso)
22. Staging Procedures to Diagnose Malignant Pleural Mesothelioma
23. Surgery for Mesothelioma After Radiation Therapy 'SMART' for Resectable Malignant Pleural Mesothelioma
24. Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
25. Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
26. Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors
27. A Study of NX-1607 in Adults With Advanced Malignancies
28. Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma
29. Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
30. CT-95 in Advanced Cancers Associated with Mesothelin Expression
31. Oral AMXT 1501 Dicaprate in Combination With IV DFMO
32. Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma (HIT-Meso)
33. A Study of Sacituzumab Govitecan in People with Mesothelioma
34. A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
35. A Study to Investigate 14C-bemcentinib in Healthy Male Subjects (8479217)
36. Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
37. Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
38. Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma
39. Dose Individualization of Pemetrexed - IMPROVE-I (IMPROVE-I)
40. Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothelioma (MPM-PDT)
41. A Study of MT027 in Patients with Pleural Malignant Tumors
42. Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
43. Dendritic Cell Vaccination for Patients with Solid Tumors
44. TTFields in General Routine Clinical Care in Patients with Pleural Mesothelioma Study (TIGER Meso)
45. Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery
46. Exercise to Boost Immunity in Advanced Cancer (BICEP)
47. HTL0039732 in Participants with Advanced Solid Tumours
48. Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
49. Mass Response of Tumor Cells As a Biomarker for Rapid Therapy Guidance (TraveraRTGx) (TraveraRTGx)
50. APG-2449 in Patients With Advanced Solid Tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.